BioSpace News Archive

Mallinckrodt plc announced that three scientific abstracts on clinical research on treatment with TERLIVAZ® for adult patients with hepatorenal syndrome involving rapid reduction in kidney function, will be presented at the American Society of Nephrology Kidney Week 2022 Scientific Meeting in Orlando, Florida, from November 3-6.

Pfizer Inc. reported solid financial results for third-quarter 2022 and updated certain components of 2022 financial guidance.

Waters Corporation announced its financial results for the third quarter of 2022.

LAVA Therapeutics N.V., a clinical stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers, announced the appointment of Fred M. Powell as Chief Financial Office.

BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported financial results for the third quarter ended September 30, 2022, and provided a corporate update.

CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, announced it will exhibit its TRANBERG™ Thermal Therapy System at the 98th Annual Western Regional AUA Meeting being held October 30th to November 4th, 2022 at the Grand Hyatt Kauai, Hawaii.

Baylis Medical Technologies Inc. is pleased to announce it is assuming responsibility for the sales and distribution of the Steerable and Guiding Sheaths currently sold direct-to-hospital by Oscor in the United States.

Veeva Systems (NYSE: VEEV) today announced a ten-year strategic partnership agreement with Merck.

ABIOMED, Inc. today announces financial results for the quarter ended September 30, 2022.

Kala Pharmaceuticals, Inc. today announced the appointment of Marjan Farid, M.D., to its Board of Directors.